A U.S. House subcommittee on Tuesday weighed whether to grant the Food and Drug Administration more authority to mandate safety recalls of cosmetic products, including asbestos-containing talcum powder.

The hearing before the Subcommittee on Economic and Consumer Policy in the U.S. House of Representatives’ Committee on Oversight and Reform, comes after the FDA last week warned consumers in a safety alert that four cosmetic products from retailers Claire’s and Justice contained asbestos, a known carcinogen. (Claire’s voluntarily recalled the products on Monday.)

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]